The products are currently sold at several large retailers including Rite-Aid, CVS, Wal-Mart and K-Mart.
As part of the transaction, all assets from Dermasilk Brands, Inc. will be transferred to Ember Therapeutics, Inc.
Ember Therapeutics executive chairman Joseph Hernandez “This is our third acquisition this year. The addition of the Dermasilk brand of products to our product line will allow us to expand on our current relationship with major retailers and provide additional revenues to Ember. Dermasilk products have a large customer following and are developed using the highest cutting edge science.
“The revenues generated by these products and Migralex, our other commercially available product, will help further the development of our two Phase 3 ready clinical programs in osteoarthritis and regenerative medicine.”
Dermasilk products are currently available at Rite-Aid, CVS, Wal-Mart, K-Mart, local pharmacies, and online at jet.com and the product website www.dermasilkbrands.com.